Spring til hovednavigation Spring til søgning Spring til hovedindhold

Current and future trial design in refractory cardiogenic shock

  • Mattia Arrigo
  • , Alice Blet
  • , Andrew Morley-Smith
  • , Nadia Aissaoui
  • , David A. Baran
  • , Antoni Bayes-Genis
  • , Ovidiu Chioncel
  • , Steffen Desch
  • , Mahir Karakas
  • , Jacob Eifer Moller
  • , Janine Poess
  • , Susanna Price
  • , Uwe Zeymer
  • , Alexandre Mebazaa*
    • *Kontaktforfatter
  • Stadtspital Zurich Triemli
  • Université de Lyon
  • Royal Brompton & Harefield NHS Foundation Trust
  • Germans Trias
  • Elias Emergency University Hospital
  • Heart Center Leipzig
  • University Medical Center Hamburg-Eppendorf
  • Klinikum Ludwigshafen
  • Université De Paris
  • Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Paris, Hôpital Cochin
  • Cleveland Clinic
  • Rigshospitalet

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

92 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftEuropean Journal of Heart Failure
Vol/bind25
Udgave nummer5
Sider (fra-til)609-615
ISSN1388-9842
DOI
StatusUdgivet - maj 2023

Bibliografisk note

Funding Information:
Open access funding provided by Universitat Zurich. Conflict of interest: D.A.B. reports consulting for Getinge, Livanova, Abbott, Abiomed and steering committee for CareDx, Procyrion and Natera, outside the current work. O.C. reports travel support from Servier, advisory boards from Boehringer Ingelheim, outside the current work. M.K. reports honoraria and research support from Adrenomed AG, and honoraria from Vifor Pharma, Sphingotec and 4TEEN4, outside the current work. J.E.M. reports research grants from Abiomed and Roche, personal honoraria from Abbott, Abiomed, Boehringer Ingelheim, Novartis, Orion Pharma, travel and material support from Abiomed, participation in advisory board from Boehringer Ingelheim, outside the current work. A.M. reports research grants from Abbott Diagnostics, Roche, Sphyngotec, 4TEEN4, advisory boards for Adrenomed, Corteria, Fire1, Roche, honoraria from Merck, Novartis, material support from Sphyngotec, outside the current work. All other authors have nothing to disclose.

Finansiering

Open access funding provided by Universitat Zurich. Conflict of interest: D.A.B. reports consulting for Getinge, Livanova, Abbott, Abiomed and steering committee for CareDx, Procyrion and Natera, outside the current work. O.C. reports travel support from Servier, advisory boards from Boehringer Ingelheim, outside the current work. M.K. reports honoraria and research support from Adrenomed AG, and honoraria from Vifor Pharma, Sphingotec and 4TEEN4, outside the current work. J.E.M. reports research grants from Abiomed and Roche, personal honoraria from Abbott, Abiomed, Boehringer Ingelheim, Novartis, Orion Pharma, travel and material support from Abiomed, participation in advisory board from Boehringer Ingelheim, outside the current work. A.M. reports research grants from Abbott Diagnostics, Roche, Sphyngotec, 4TEEN4, advisory boards for Adrenomed, Corteria, Fire1, Roche, honoraria from Merck, Novartis, material support from Sphyngotec, outside the current work. All other authors have nothing to disclose.

Dokumenter og links

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

    Citationsformater